The thyrotropin (TSH) receptor is a putative target for autoantibodies in Graves' hyperthyroidism and therefore, should be capable of being identified, isolated, and structurally characterized by immunological means. To this end, four sera from patients with hyperthyroidism, three of which inhibited the binding of 125I-TSH to Triton-solubilized human thyroid membranes, were used to isolate TSH receptors by immunoprecipitation. To account for an effect of TSH binding or receptor occupancy on the ability of Graves' immunoglobulins to precipitate TSH receptors, two approaches were taken: (a) specific 125I-TSH binding activity was measured after solubilized thyroid membranes had been incubated with Graves' sera followed by precipitation with Staphylococcus protein A ("receptor depletion"); (b) TSH binding sites were labeled with 125I-TSH and the complexes were precipitated using Graves' sera and Staphylococcus protein A ("receptor precipitation"). The three sera which inhibited 125I-TSH binding depleted 125I-TSH binding activity between 30-80%. Preformed complexes between Staphylococcus protein A and immunoglobulins in these sera were also able to deplete 125I-TSH binding activity. However, after receptor depletion, the one serum that did not inhibit 125I-TSH binding was associated with a significant increase in 125I-TSH binding. All four sera specifically precipitated 80-100% of receptors identified by prelabeling with 125I-TSH. The dilutions of sera that precipitated 50% of 125I-TSH-receptor complexes ranged from 1:150-1:20. Complexes were partially precipitated by high concentrations of control sera (1:20), but the relative potency of control sera was at least fourfold less than Graves' sera. Immunoprecipitates of 125I-labeled thyroid membranes were analysed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography to reveal Graves'-specific bands of reduced molecular weights of 100-110,000, 80-90,000, and 70-75,000. These bands were similar to those obtained from 125I-labeled thyroid membranes purified by TSH affinity chromatography. Thus, Graves' immunoglobulins: (a) precipitate unoccupied and occupied TSH receptors, (b) in one case, neither inhibit binding nor immunodeplete the unoccupied receptor but immunoprecipitate 125I-TSH-receptor complexes, suggesting that binding of TSH may initiate an interaction between the binding site and a separate immunoreactive molecule, and (c) identify the molecular structure of Graves' autoantigens, putatively, the TSH receptor.
P Heyma, L C Harrison
Title and authors | Publication | Year |
---|---|---|
Effect of a Low-Molecular-Weight Allosteric Agonist of the Thyroid-Stimulating Hormone Receptor on Basal and Thyroliberin-Stimulated Activity of Thyroid System in Diabetic Rats
Derkach KV, Pechalnova AS, Sorokoumov VN, Zorina II, Morina IY, Chernenko EE, Didenko EA, Romanova IV, Shpakov AO |
International Journal of Molecular Sciences | 2025 |
Molecular mimicry and autoimmunity in the time of COVID-19
Rojas M, Herrán M, Ramírez-Santana C, Leung PS, Manuel-Anaya J, Ridgway WM, Gershwin ME |
Journal of Autoimmunity | 2023 |
Comparative Study of the Steroidogenic Effects of Human Chorionic Gonadotropin and Thieno[2,3-D]pyrimidine-Based Allosteric Agonist of Luteinizing Hormone Receptor in Young Adult, Aging and Diabetic Male Rats
AA Bakhtyukov, KV Derkach, MA Gureev, DV Darin, VN Sorokoumov, IV Romanova, IY Morina, AM Stepochkina, AO Shpakov |
International journal of molecular sciences | 2020 |
TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective
B Rapoport, SM McLachlan |
Endocrine reviews | 2016 |
Withdrawn: TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.
Rapoport B, McLachlan SM |
Endocrine reviews | 2016 |
Peptide 612–627 of thyrotropin receptor and its modified analogs as regulators of adenylyl cyclase in rat thyroid gland
AO Shpakov, EA Shpakova, II Tarasenko, KV Derkach |
Cell and Tissue Biology | 2014 |
The Thyrotropin (TSH)-Releasing Hormone Receptor: Interaction with TSH and Autoantibodies 1
B Rapoport, GD Chazenbalk, JC Jaume, SM McLachlan |
Endocrine reviews | 1998 |
Autoimmunity and reproduction
E Geva, A Amit, L Lerner-Geva, JB Lessing |
Fertility and Sterility | 1997 |
Thyrotropin Receptor Autoantibodies in Serum Are Present at Much Lower Levels Than Thyroid Peroxidase Autoantibodies: Analysis by Flow Cytometry*
JC Jaume, A Kakinuma, GD Chazenbalk, B Rapoport, SM McLachlan |
The Journal of clinical endocrinology and metabolism | 1997 |
Autoimmune endocrinopathies 2 Recombinant thyroid autoantigens: the keys to the pathogenesis of autoimmune thyroid disease
SM McLACHLAN, B Rapoport |
Journal of Internal Medicine | 1993 |
Immunogenicity of a unique region of the human thyrotropin receptor
EV Nagy, HB Burch, YG Lukes, FE Carr, S Kosugi, LD Kohn, KD Burman |
Journal of Endocrinological Investigation | 1993 |
Two-subunit structure of the human thyrotropin receptor
H Loosfelt, C Pichon, A Jolivet, M Misrahi, B Caillou, M Jamous, B Vannier, E Milgrom |
Proceedings of the National Academy of Sciences | 1992 |
Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors
Y Nagayama, HL Wadsworth, D Russo, GD Chazenbalk, B Rapoport |
Journal of Clinical Investigation | 1991 |
Direct evidence that ganglioside is an integral component of the thyrotropin receptor
W Kielczynski, LC Harrison, PJ Leedman |
Proceedings of the National Academy of Sciences | 1991 |
The Structure of Thyroid Autoantigens
J Furmaniak, BR Smith |
Autoimmunity | 1990 |
The thyroid stimulating hormone receptor in human disease
LC Harrison, PJ Leedman |
Clinical Biochemistry | 1990 |
Heterogeneity of TSH Receptor-binding Antibodies in Hashimoto’s Thyroiditis and Graves’ Disease
TW de Bruin, LE Braverman, RS Brown |
The American Journal of the Medical Sciences | 1990 |
Receptor Purification
G Litwack |
1990 | |
Ovarian failure and autoimmunity. Detection of autoantibodies directed against both the unoccupied luteinizing hormone/human chorionic gonadotropin receptor and the hormone-receptor complex of bovine corpus luteum
H Moncayo, R Moncayo, R Benz, A Wolf, C Lauritzen |
Journal of Clinical Investigation | 1989 |
Binding of thyrotropin to selected mycoplasma species: detection of serum antibodies against a specific mycoplasma membrane antigen in patients with autoimmune thyroid disease
J Sack, D Zilberstein, MF Barile, YG Lukes, JR Baker, L Wartofsky, KD Burman |
Journal of Endocrinological Investigation | 1989 |
Difference in species specificity of TSH receptor antibodies in Graves’ disease and Hashimoto’s thyroiditis
TW Bruin |
Journal of Endocrinological Investigation | 1988 |
5 Human autoimmune thyroid disease: Cellular and molecular aspects
TF Davies, A Martin, P Graves |
Baillière's Clinical Endocrinology and Metabolism | 1988 |
Islet-specific immune mechanisms
ÅK Lernmark, S Li, S Baekkeskov, M Christie, B Michelsen, J Ursing, ML Olsson, G Sundkvist |
Diabetes / Metabolism Reviews | 1987 |
Interaction of the thyrotropin receptor on rat FRTL-5 thyroid cells with thyrotropin and a thyrotropin-stimulating autoantibody from Graves' patients
L Bartalena, G Fenzi, P Vitti, D Tombaccini, A Antonelli, E Macchia, L Chiovato, LD Kohn, A Pinchera |
Biochemical and Biophysical Research Communications | 1987 |
Thyroid Autoimmunity
A Pinchera, SH Ingbar, JM McKenzie, GF Fenzi |
1987 | |
Thyrotrophin (TSH) binding sites on Yersinia enterocolitica recognized by immunoglobulins from humans with Graves' disease
P Heyma, LC Harrison, R Robins-Browne |
Clinical & Experimental Immunology | 1986 |
The interaction between the TSH receptor and Graves' sera with TSH agonist or antagonist properties
ED Jones, FA Hashim, FM Creagh, SE Williams, BR Smith |
Molecular and Cellular Endocrinology | 1985 |
The Autoimmune Diseases I
PB Ferrell, EM Tan |
The Autoimmune Diseases I | 1985 |